3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Safety Issues: new trials by email Literature Review of Safety Issues trials Research Report on Safety Issues
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection 15 mg ADC189, 45 mg ADC189, Placebo - Safety Issues, Effect of Drug | Phase 2 / Phase 3 | Completed | Jiaxing AnDiCon Biotech Co.,Ltd | 749 | 2022-12-07 | 2025-01-21 |
| Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III) Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi Polysaccharide Vaccine - Safety Issues, Immunogenicity | Phase 3 | Completed | PT Bio Farma | 3071 | 2020-03-02 | 2022-01-04 |
| Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy Béfizal - Safety Issues, Efficacy, Self | Phase 2 / Phase 3 | Completed | Hôpital Necker-Enfants Malades | 14 | 2019-03-26 | 2023-09-22 |
Bezafibrate (1) · Vi polysaccharide vaccine, typhoid (1)
Hôpital Necker-Enfants Malades (1) · Jiaxing AnDiCon Biotech Co.,Ltd (1) · PT Bio Farma (1)
China (1) · France (1) · Indonesia (1)
Bernie E Medise, MD (1) · Dominique Bremond Gignac, MD PhD (1)